Covered endovascular reconstruction of the aortic bifurcation: A systematic review aggregated data and individual participant data meta-analysis
Journal of Vascular Surgery · 2024-06 · 79 (6) · 1525-1535.e9
DOI: 10.1016/j.jvs.2023.12.021 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Vascular Surgery, 2024-06. Verfasst von Vangelis Bontinis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece. Electronic address: va…. Hauptthemen laut MEDLINE: Endovascular Procedures, Vascular Patency, Blood Vessel Prosthesis Implantation, Aortic Diseases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: We investigated the early and midterm efficacy and safety of covered endovascular reconstruction of the aortic bifurcation (CERAB) in the treatment of aortoiliac disease (AID). METHODS: A systematic search on PubMed, Scopus, and Web of Science for articles published by August 2023 was performed. The primary end points were primary patency and secondary patency. RESULTS: Eleven retrospective case series, involving 579 patients, were incorporated in the review with 88.9% of the included lesions being categorized as Trans-Atlantic Inter-Society Consensus (TASC) C or D. The pooled primary patency estimates at 12, 24 and 36 months were 94.4% (95% confidence interval [CI], 89.4-99.7), 84.4% (95% CI, 72.3-98.5) and 83.8% (95% CI, 71.4-98.3) respectively. The mean primary patency time, representing the period during which individuals remained event-free, was 51.9 months (95% CI, 43.6-55.4). The pooled 36 months primary patency for studies with a predominantly claudicant patient population (>75% of patients) was 89.4% (95% CI, 78.5-100.0), compared with 71.5% (95% CI, 45.6-100.0) for studies with a mixed population (50% of patients). The pooled 36 months primary patency for studies with a predominantly TASC D patient population (>82% of patients) was 70.4% (95% CI, 46.4-100.0) compared with 91.0% (95% CI, 79.1-100.0) for studies with a more homogenous cohort. The pooled secondary patency estimates at 12, 24, and 36 months were 98.6% (95% CI, 96.2-100.0), 97% (95% CI, 93.1-100.0), and 97% (95% CI, 93.1-100.0), respectively. The pooled technical success, 30-day mortality and 30-day systemic complications estimates were 95.9% (95% CI, 93.7- 97.4), 1.9% (95% CI, 1.0-3.5), and 6.4% (95% CI, 4.4-9.1), respectively. The pooled intraoperative and postoperative 30-day CERAB-related complications estimates were 7.3% (95% CI, 2.0-23.0) and 4.2% (95% CI, 0.7-21.0), respectively. The pooled major amputation and target lesion reinterventions by the end of follow-up were 1.9% (95% CI, 1.0-3.4) and 13.9% (95% CI, 9.9-19.2), respectively. The pooled access site complication estimate was 11.7% (95% CI, 5.9-21.7). CONCLUSIONS: Although this review has showcased the safety and feasibility of the CERAB technique in treating AID, it has also highlighted the necessity for a close and prolonged follow-up period extending beyond 1 year. Moreover, the favorable secondary patency estimates predominantly attained via endovascular reinterventions emphasize a potentially advantageous characteristic of the CERAB technique, particularly valuable when addressing late-stage AID disease or anatomically complex lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece. Electronic address: vangelisbont@hotmail.com.
- Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece.
- Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross General Hospital, Athens, Greece.
Zitieren
APA
Bontinis, V., Bontinis, A., Giannopoulos, A., Manaki, V., Kontes, I., Papas, T., Giannakopoulos, N. N., & Ktenidis, K. (2024). Covered endovascular reconstruction of the aortic bifurcation: A systematic review aggregated data and individual participant data meta-analysis. Journal of Vascular Surgery, 79(6), 1525-1535.e9. https://doi.org/10.1016/j.jvs.2023.12.021
Vancouver
Bontinis V, Bontinis A, Giannopoulos A, Manaki V, Kontes I, Papas T, et al. Covered endovascular reconstruction of the aortic bifurcation: A systematic review aggregated data and individual participant data meta-analysis. Journal of Vascular Surgery. 2024;79(6):1525-1535.e9. doi:10.1016/j.jvs.2023.12.021
BibTeX
@article{Bontinis2024,
author = {Bontinis, Vangelis and Bontinis, Alkis and Giannopoulos, Argirios and Manaki, Vasiliki and Kontes, Ioannis and Papas, Theofanis and Giannakopoulos, Nikolaos-Nektarios and Ktenidis, Kiriakos},
title = {Covered endovascular reconstruction of the aortic bifurcation: A systematic review aggregated data and individual participant data meta-analysis},
journal = {Journal of Vascular Surgery},
year = {2024},
volume = {79},
number = {6},
pages = {1525--1535.e9},
doi = {10.1016/j.jvs.2023.12.021}
}
EUVIMED